Literature DB >> 23863902

VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.

Shuguang Tan1, Xiaojuan Tan, Xiaoman Sun, Guangwen Lu, Chun-Chi Chen, Jinghua Yan, Jun Liu, Wenbo Xu, George F Gao.   

Abstract

Enterovirus 71 (EV71)-associated hand-foot-mouth disease has become a major threat to public health in the Asia-Pacific region. Although T cell immunity is closely correlated with clinical outcomes of EV71 infection, little is known about T cell immunity baseline against EV71 and T cell immunogenecity of EV71 Ags in the population, which has restricted our understanding of immunoprotection mechanisms. In this study, we investigated the cellular immune responses against the four structural Ags of EV71 and determined the immunohierarchy of these Ags in healthy adults. A low frequency of EV71-responsive T cells was detected circulating in peripheral blood, and broad T cell immune responses could be identified in most of the subjects after in vitro expansion. We demonstrated that the VP2 Ag with broad distribution of immunogenic peptides dominates T cell responses against EV71 compared with VP1, VP3, and VP4. Furthermore, the responses were illuminated to be mainly single IFN-γ-secreting CD4(+) T cell dependent, indicating the previous natural acute viral infection of the adult population. Conservancy analysis of the immunogenic peptides revealed that moderately variant peptides were in the majority in coxsackievirus A16 (CV-A16) whereas most of the peptides were highly variant in polioviruses. Less efficient cross-reactivity against CV-A16 might broadly exist among individuals, whereas influences derived from poliovirus vaccination would be limited. Our findings suggest that the significance of VP2 Ag should be addressed in the future EV71-responsive immunological investigations. And the findings concerning the less efficient cross-reactivity against CV-A16 and limited influences from poliovirus vaccination in EV71-contacted population would contribute to a better understanding of immunoprotection mechanisms against enteroviruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863902     DOI: 10.4049/jimmunol.1301439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Adaptive Immune Responses following Senecavirus A Infection in Pigs.

Authors:  Mayara F Maggioli; Steve Lawson; Marcelo de Lima; Lok R Joshi; Tatiane C Faccin; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

2.  A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis.

Authors:  Alba Grifoni; Swapnil Mahajan; John Sidney; Sheridan Martini; Richard H Scheuermann; Bjoern Peters; Alessandro Sette
Journal:  Hum Immunol       Date:  2019-08-23       Impact factor: 2.850

3.  The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.

Authors:  Qunying Mao; Yiping Wang; Jie Shao; Zhifang Ying; Fan Gao; Xin Yao; Changgui Li; Qiang Ye; Miao Xu; Rongcheng Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015-02-25       Impact factor: 3.452

4.  Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.

Authors:  Kam Leng Aw-Yong; I-Ching Sam; Mia Tuang Koh; Yoke Fun Chan
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

Review 5.  T Cell Immunity To Enterovirus 71 Infection In Humans And Implications For Vaccine Development.

Authors:  Pinn Tsin Isabel Yee; Chit Laa Poh
Journal:  Int J Med Sci       Date:  2018-07-25       Impact factor: 3.738

6.  Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice.

Authors:  Pinn Tsin Isabel Yee; Soon Hao Tan; Kien Chai Ong; Kuan Onn Tan; Kum Thong Wong; Sharifah Syed Hassan; Chit Laa Poh
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

7.  Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.

Authors:  Chia-Chyi Liu; Chyi-Sing Hwang; Wun-Syue Yang; Dan-Chin Tsai; Sze-Hsien Wu; Ai-Hsiang Chou; Yen-Hung Chow; Suh-Chin Wu; Jen-Ren Wang; Jen-Ron Chiang; Chin-Cheng Huang; Chien-Hsiung Pan; Pele Chong
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

8.  The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway.

Authors:  Lei Zhu; Weihua Li; Gongjian Qi; Na Liu; Liping Sheng; Lei Shang; Boxiang Qi
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

Review 9.  Insights into innate and adaptive immune responses in vaccine development against EV-A71.

Authors:  Hui Xuan Lim; Chit Laa Poh
Journal:  Ther Adv Vaccines Immunother       Date:  2019-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.